- Home
- PCVX vs NXE Comparison
PCVX vs NXE Comparison
Compare PCVX & NXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PCVX | NXE |
|---|---|---|
| Founded | 2013 | 2011 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.9B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PCVX | NXE |
|---|---|---|
| Price | $46.76 | $9.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $101.67 | N/A |
| AVG Volume (30 Days) | 1.5M | ★ 7.3M |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.66 | $3.91 |
| 52 Week High | $94.60 | $9.99 |
Technical Indicators
Market Signals| Indicator | PCVX | NXE |
|---|---|---|
| Relative Strength Index (RSI) | 51.97 | 58.65 |
| Support Level | $43.78 | $8.86 |
| Resistance Level | $48.11 | $9.99 |
| Average True Range (ATR) | 1.99 | 0.48 |
| MACD | -0.49 | 0.18 |
| Stochastic Oscillator | 42.99 | 78.01 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About NXE Nexgen Energy Ltd.
NexGen Energy Ltd is an exploration and development entity engaged in acquiring, evaluating, and developing uranium properties in Canada. The company's projects portfolio consists of ROOK I, and the IsoEnergy, at the Athabasca Basin.